Konstantin Poukalov, Director, 10% Owner at Landos Biopharma, Inc. (LABP), bought 14,619,728 shares at $16.00 ($20.0M) on 2021-02-08, disclosed to the SEC on 2021-02-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 13,369,728 | $0 | 0.0% |
| 2 | $16.00 | 1,250,000 | $20.0M | 100.0% |
| Total | $1.37 avg | 14,619,728 | $20.0M | 100% |
| Filing → |